Treat it as historical in vitro data rather than in-human evidence, the original study used cultured cells, not human subjects [16][17]
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
Pountos, I., Panteli, M., Lampropoulos, A
Atomic model refinement The initial template for the AMYR:Cagri/CagriBB complex was generated by changing the divergent resides of rAmy in the corresponding AMYR:rAmy complex (PDB: 7TYF,7TYX, 7TZF)
GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Pickart and Thaler in 1973
Garcia-Segura LM, Veiga S, Sierra A, Melcangi RC, Azcoitia I
